Logo image
IRO Home Research units Researcher Profiles
Sign in
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Journal article   Peer reviewed

Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

Andrew S Bomback, Gerald B Appel, Debbie S Gipson, Michelle A Hladunewich, Richard Lafayette, Carla M Nester, Samir V Parikh, Richard J.H Smith, Howard Trachtman, Peter S Heeger, …
American journal of kidney diseases, Vol.79(4), pp.570-581
04/2022
DOI: 10.1053/j.ajkd.2021.07.025
PMID: 34571062

View Online

Abstract

clinical trial design complement biomarkers complement blockade complement inhibition complement-mediated glomerulopathy drug approval pathway drug safety Glomerular disease glomerulonephritides infectious risk patient-reported outcome (PRO) rare diseases research priorities surrogate outcome trial end points

Details

Logo image